Worldwide distributor of NSN parts and consumables located in the USA.
Send us a request for quote using the form below. Our team will contact you with an up to date pricing and availability quote ASAP.
Dermatological agents and local anesthetics put up in measured doses or in forms or packings for retail sale, nesoi
Medicaments, n.E.S., in dosage form or retail packings
Pharmaceutical preparations
Y - Indicates information is in the hazardous materials information resource system (hmirs).
PMICA - Item does not contain precious metal.
CRITL- The item does not have a nuclear hardened feature or any other critical feature such as tolerance, fit restriction or application.
058770 - Drugs/medicines/vitamins noi
532 - Drugs and medicines excluding pencillin, sulfa, serums, vaccines, and vitamins (not requiring temperature control)
9 - Other or no special handling required (sh)
A - Shipment is not a consolidation and does not exceed 84 inches in any dimension.
H - Subject to damage from heat
M - Medical supplies, equipment, samples, records, etc.
W - Rating variable
Questions & Answers: |
|
What are the historical prices recorded for this stock number? | |
Historical data shows pricing from $319.55 to $532.58.. | |
Does NSN 6505-00-116-0200 have a shelf life? | |
No. There is no shelf life applicable for this NSN. | |
What NATO entities are users of this NSN? | |
Department Of The Army, Department Of The Air Force, U.s. Marine Corps, Department Of The Navy, Singapore, Kuwait, and New Zealand | |
What is the NIIN of NSN 6505-00-116-0200? | |
001160200 or 00-116-0200 | |
Does NSN 6505-00-116-0200 require demilitarization? | |
Yes - ITAR Controlled | |
What is the most recent solicitation for NSN 6505-00-116-0200? | |
No solicitations for this NSN. | |
When was this national stock number assigned to the federal catalog? | |
Jan 01, 1963 |
Ld50 lc50 mixture: oral rat ld50 2212 mg/kg
routes of entry: inhalation: no skin: yes ingestion: no
reports of carcinogenicity: ntp: no iarc: no osha: no
explanation of carcinogenicity: carcinogenity studies have not been
conducted.
effects of overexposure: none
medical cond aggravated by exposure: do not use on inflamed,raw,or
weeping surfaces; nor in eyes or mouth.
First aid: eye: flush with water. Ingested: no specified antidote. Reduce
absorption and eliminate drug. Get medical attention.
Hcc: n1
boiling pt: b.P. Text: 212f/100c
spec gravity: >1
appearance and odor: white to yellowish cream with charac perfumgo odor
Stability indicator/materials to avoid: yes
none
stability condition to avoid: none
hazardous decomposition products: none
Waste disposal methods: dispose of as ordinary waste.
disclaimer (provided with this information by the compiling agencies):
this information is formulated for use by elements of the department
of defense. the united states of america in no manner whatsoever,
expressly or implied, warrants this information to be accurate and
disclaims all liability for its use. any person utilizing this
document should seek competent professional advice to verify and
assume responsibility for the suitability of this information to their
particular situation.
Ingred name: n-ethyl-o-crotonotoluidide (crotamiton)
cas: 483-63-6
rtecs #: gq7000000
fraction by wt: 10%